ACH
IBB icon

ArrowMark Colorado Holdings’s iShares Biotechnology ETF IBB Stock Holding History

ArrowMark Colorado Holdings’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-4,356
Closed -$304K – 327
2013
Q3 		$304K Buy
+4,356
New +$285K 0.01% 274

Other funds holding IBB

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

ArrowMark Colorado Holdings's IBB Position: Q4 2013 in Review

ArrowMark Colorado Holdings sold out of iShares Biotechnology ETF (IBB) in Q4 2013, closing a stake of 4,356 shares — an estimated $304K sold.

ArrowMark Colorado Holdings first reported a position in IBB in Q3 2013 and held it in 1 quarter. The position peaked at $304K in Q3 2013. 278 funds tracked by Wall St. Rank hold IBB as of Q4 2013.

  • ArrowMark Colorado Holdings reported no remaining iShares Biotechnology ETF position as of Q4 2013 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 4,356 iShares Biotechnology ETF shares in Q4 2013, an estimated $304K.
  • ArrowMark Colorado Holdings first reported a position in iShares Biotechnology ETF in Q3 2013 and held it in 1 quarter.
  • ArrowMark Colorado Holdings's iShares Biotechnology ETF position peaked at $304K in Q3 2013.
  • 278 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2013.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2013, filed 14 Feb 2014.